To address this issue, aptamers have been developed for the detection of a number of cancer-related biomarkers [102], including multiple tumor-related proteins in living cancer cells, such as MUC1 (mucin 1), HER2 (human epidermal growth factor receptor 2), and estrogen receptor [102]. This evidence concerns the gene MUC1 and neoplasm.